<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Nitinol Medical Technologies, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
65476T104
------------------------------
(CUSIP Number)
December 31, 1998
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 pages
<PAGE>
Page 2 of 5 pages
CUSIP NO. 65476T104
-------------
- ------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS.
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
C. Leonard Gordon, SS#:_______________
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
United States of America
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
279,925 shares which Mr. Gordon has the right to
NUMBER OF acquire within 60 days after December 31, 1998.
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
509,619 shares (includes 15,000 shares held in the
OWNED BY name of Mr. Gordon's wife for which Mr. Gordon holds
a power of attorney)
EACH -----------------------------------------------------------
SOLE DISPOSITIVE POWER
REPORTING 7
279,925 shares which Mr. Gordon has the right to
PERSON acquire within 60 days after December 31, 1998.
WITH: -----------------------------------------------------------
SHARED DISPOSITIVE POWER
8
509,619 shares (includes 15,000 shares held in the
name of Mr. Gordon's wife for which Mr. Gordon holds
a power of attorney)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
789,544 shares (includes 279,925 shares which Mr. Gordon has the right to
acquire within 60 days after December 31, 1998)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
Not Applicable.
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.2%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
IN
- ------------------------------------------------------------------------------
<PAGE>
Page 3 of 5 pages
CUSIP NO. 65476T104
- --------------------
Item 1(a) Name of Issuer:
- --------- --------------
Nitinol Medical Technologies, Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
- --------- ----------------------------------------------
27 Wormwood Street
Boston, MA 02210
Item 2(a) Name of Person Filing:
- --------- ---------------------
C. Leonard Gordon
Item 2(b) Address of Principal Business Office or, if none, Residence:
- --------- -----------------------------------------------------------
Immunotherapy, Inc.
360 Lexington Avenue
New York, New York 10017
Item 2(c) Citizenship:
- --------- -----------
United States of America
Item 2(d) Title of Class of Securities:
- --------- ----------------------------
Common Stock, $.001 par value per share.
Item 2(e) CUSIP Number:
- --------- ------------
65476T104
Item 3 Description of Person Filing:
- ------ ----------------------------
Not Applicable.
Item 4 Ownership:
- ------ ---------
(a) Amount beneficially owned:
-------------------------
789,544 shares (includes 279,925 shares which Mr. Gordon has
the right to acquire within 60 days after December 31, 1998)
(b) Percent of class:
----------------
7.2%
(c) Number of shares as to which the person has:
-------------------------------------------
(i) sole power to vote or to direct the vote:
279,925 shares which Mr. Gordon has the right to acquire
within 60 days after December 31, 1998
(ii) shared power to vote or to direct the vote:
509,619 shares (includes 15,000 shares held in the name
of Mr. Gordon's wife for which Mr. Gordon holds a power
of attorney)
(iii) sole power to dispose or to direct the disposition of:
279,925 shares which Mr. Gordon has the right to acquire
within 60 days after December 31, 1998
(iv) shared power to dispose or to direct the disposition of:
509,619 shares (includes 15,000 shares held in the name
of Mr. Gordon's wife for which Mr. Gordon holds a power
of attorney)
Item 5 Ownership of Five Percent or Less of a Class.
- ------ --------------------------------------------
Not applicable.
<PAGE>
Page 4 of 5 pages
CUSIP NO. 65476T104
- --------------------
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
- ------ ----------------------------------------------------------------
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which Acquired the
- ------ ----------------------------------------------------------------------
Security Being Reported on by the Parent Holding Company:
--------------------------------------------------------
Not applicable.
Item 8 Identification and Classification of Members of the Group:
- ------ ---------------------------------------------------------
Not applicable.
Item 9 Notice of Dissolution of Group:
- ------ ------------------------------
Not applicable.
Item 10 Certification:
- ------- -------------
Not applicable.
<PAGE>
Page 5 of 5 pages
CUSIP NO. 65476T104
- --------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: February 10, 1999 /s/ C. Leonard Gordon
--------------------------------
C. Leonard Gordon
